Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$77.94
-0.5%		$86.79
$54.11
▼
$92.59
$29.55B1.483.80 million shs5.22 million shs
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$12.88
+0.9%		$12.93
$10.33
▼
$33.93
$28.77B0.6397,294 shs92,710 shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$26.90
-0.1%		$25.54
$23.62
▼
$33.44
$26.46B0.771.23 million shs1.34 million shs
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$12.34
-0.9%		$11.92
$8.01
▼
$13.01
$7.58B1.18497,291 shs125,278 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-0.49%-9.41%-11.16%+8.95%+10.24%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
+1.57%+1.34%-2.57%+3.21%-14.08%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
+0.00%+4.47%+9.94%+2.83%-5.78%
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
-0.80%+5.74%+5.20%+32.83%+2.92%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$77.94
-0.5%		$86.79
$54.11
▼
$92.59
$29.55B1.483.80 million shs5.22 million shs
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$12.88
+0.9%		$12.93
$10.33
▼
$33.93
$28.77B0.6397,294 shs92,710 shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$26.90
-0.1%		$25.54
$23.62
▼
$33.44
$26.46B0.771.23 million shs1.34 million shs
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$12.34
-0.9%		$11.92
$8.01
▼
$13.01
$7.58B1.18497,291 shs125,278 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-0.49%-9.41%-11.16%+8.95%+10.24%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
+1.57%+1.34%-2.57%+3.21%-14.08%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
+0.00%+4.47%+9.94%+2.83%-5.78%
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
-0.80%+5.74%+5.20%+32.83%+2.92%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
3.04
Buy$92.4318.60% Upside
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
3.00
BuyN/AN/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
2.00
HoldN/AN/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest SSMXY, DXCM, FSNUY, and PHG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/21/2026
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
10/13/2026
DexCom, Inc. stock logo
DXCM
DexCom
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price Target$100.00
10/12/2026
DexCom, Inc. stock logo
DXCM
DexCom
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$90.00 ➝ $96.00
10/7/2026
DexCom, Inc. stock logo
DXCM
DexCom
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeStrong-Buy
10/6/2026
DexCom, Inc. stock logo
DXCM
DexCom
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access to unlock brokerage rankings
Initiated CoverageUnderweight ➝ Overweight$115.00
10/6/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
10/6/2026
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold (C+) ➝ Hold (C)
10/1/2026
DexCom, Inc. stock logo
DXCM
DexCom
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingOutperform$90.00 ➝ $105.00
9/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Set Price TargetBuy$93.00 ➝ $102.00
9/18/2026
DexCom, Inc. stock logo
DXCM
DexCom
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingBuy$95.00
8/18/2026
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeStrong Sell ➝ Hold
(Data available from 10/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B6.31$2.76 per share28.29$7.04 per share11.07
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$25.87B1.12$1.58 per share8.16$9.93 per share1.30
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$20.17B1.31$3.09 per share8.71$12.91 per share2.08
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$3.32B2.26$0.85 per share14.47$5.30 per share2.33
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5330.7125.311.3120.12%35.94%14.75%10/29/2026 (Estimated)
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$1.43B$0.7912.9011.20N/A6.67%10.25%4.87%11/4/2026 (Estimated)
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$1.01B$1.3614.0914.0811.196.30%14.38%5.96%11/3/2026 (Estimated)
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$234.01M$0.4229.3826.26N/A7.62%8.01%5.61%11/4/2026 (Estimated)

Latest SSMXY, DXCM, FSNUY, and PHG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/4/2026N/A
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$0.2156N/AN/AN/A$6.51 billionN/A
11/4/2026N/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$0.0944N/AN/AN/A$854.07 millionN/A
11/3/2026Q3 2026
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.37N/AN/AN/A$5.02 billionN/A
10/29/2026Q3 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6750N/AN/AN/A$1.33 billionN/A
8/7/2026Q1 2027
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$0.07$0.09+$0.02$0.09$741.67 million$825.85 million
8/5/2026Q2 2026
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$0.25$0.24-$0.01$0.20$6.65 billion$6.91 billion
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
7/27/2026Q2 2026
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.40$0.57+$0.17$0.46$4.91 billion$4.98 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
$0.201.55%N/A25.32%N/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.843.12%-13.87%61.76%N/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
$0.141.13%N/A33.33%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
0.41
1.28
0.97
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.55
1.26
0.82
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
0.23
3.40
2.53

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
N/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
13.67%
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
N/A

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
N/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
N/A
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
Fresenius SE & Co. stock logo
FSNUY
Fresenius SE & Co.
178,3942.25 billionN/ANot Optionable
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
65,340982.89 millionN/AOptionable
Sysmex Corporation ADR stock logo
SSMXY
Sysmex
11,731608.34 millionN/ANot Optionable

Recent News About These Companies

Sysmex Corporation ADR (OTCMKTS:SSMXY) Stock Short Interest Declines 44.9%
October 17, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31128309
Sysmex Corp ADR (SSMXY)
October 10, 2026  |  investing.comhttps://www.investing.com/equities/sysmex-corp-financial-summary
Sysmex Corp (SSMXY)
September 13, 2026  |  es.investing.comhttps://es.investing.com/equities/sysmex-corp
Sysmex Corporation (SSMXY) Latest Press Releases & Corporate News - Yahoo Finance
August 24, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/SSMXY/press-releases/
Sysmex Corp (SSMXY) Ratios
August 24, 2026  |  uk.investing.comhttps://uk.investing.com/equities/sysmex-corp-ratios
Sysmex Corporation (SSMXY) Latest Stock News & Headlines - Yahoo Finance
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/SSMXY/news/
Sysmex Corporation (SSMXY) Q1 2027 Earnings Call Prepared Remarks Transcript
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935310-sysmex-corporation-ssmxy-q1-2027-earnings-call-prepared-remarks-transcript
Sysmex Corporation (SSMXY) Stock Earnings Call Transcripts - Yahoo Finance
July 25, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/SSMXY/earnings-calls/
Sysmex Corporation (SSMXY) Stock Price, News, Quote & History - Yahoo Finance
June 24, 2026  |  ca.finance.yahoo.comhttps://ca.finance.yahoo.com/quote/SSMXY/
Sysmex Corporation (SSMXY) latest press releases and corporate news – Yahoo Finance
June 19, 2026  |  sg.finance.yahoo.comhttps://sg.finance.yahoo.com/quote/SSMXY/press-releases/
Sysmex Corp Stock Price History
May 18, 2026  |  investing.comhttps://www.investing.com/equities/sysmex-corp-historical-data
SSMXY Share News Today
May 14, 2026  |  uk.investing.comhttps://uk.investing.com/equities/sysmex-corp-news
Sysmex Stock Short Interest Report | OTC:SSMXY | Benzinga
May 14, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SSMXY/short-interest
Sysmex Corporation (SSMXY) stock price, news, quote and history - Yahoo Finance
March 13, 2026  |  au.finance.yahoo.comhttps://au.finance.yahoo.com/quote/SSMXY/
Sysmex Strengthens Diagnostic Capabilities with Strategic Acquisition
September 3, 2025  |  aktiencheck.deA
Sysmex America Gets Health Canada License for Blood Coagulation Analyzers
June 25, 2025  |  360dx.com3
Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care
April 15, 2025  |  informazione.itI
Macrium Software: Macrium Partners with Sysmex America to Reduce Medical Testing Downtime and Improve Patient Care
April 15, 2025  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2025-04/65123998-macrium-software-macrium-partners-with-sysmex-america-to-reduce-medical-testing-downtime-and-improve-patient-care-008.htm
Sysmex’s PA-100 AST System: Revolutionising UTI diagnosis and treatment with precision
April 2, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/sysmex-pa-100-ast-system-104800621.html
Sysmex’s PA-100 AST System Transforms UTI Diagnosis and Antibiotic Selection with Groundbreaking Speed
April 1, 2025  |  financial-news.co.ukhttps://www.financial-news.co.uk/sysmexs-pa-100-ast-system-transforms-uti-diagnosis-and-antibiotic-selection-with-groundbreaking-speed/

New MarketBeat Followers Over Time

Media Sentiment Over Time

DexCom stock logo

DexCom NASDAQ:DXCM

$77.94 -0.38 (-0.49%)
Closing price 10/23/2026 04:00 PM Eastern
Extended Trading
$78.53 +0.59 (+0.75%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Fresenius SE & Co. stock logo

Fresenius SE & Co. OTCMKTS:FSNUY

$12.88 +0.11 (+0.86%)
As of 10/23/2026 03:59 PM Eastern

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$26.90 -0.02 (-0.09%)
Closing price 10/23/2026 03:59 PM Eastern
Extended Trading
$26.90 0.00 (0.00%)
As of 10/23/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Sysmex stock logo

Sysmex OTCMKTS:SSMXY

$12.34 -0.12 (-0.95%)
As of 10/23/2026 03:52 PM Eastern

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas